Topical or oral corticosteroids generally cost $10 to $20 a month.

The retrospective analysis, published in the Journal of Clinical Medicine, supports the use of tildrakizumab, an interleukin-23 (IL-23) inhibitor that was FDA approved in 2018 for moderate-to-severe ...

New research shows risankizumab delivers long-term psoriasis control, with OCT revealing reduced subclinical inflammation.

NEW YORK (Reuters Health) - People with psoriasis taking drugs such as etanercept (Enbrel) and adalimumab (Humira) were less likely to have a heart attack than those who were only treated with milder ...

Knowing your psoriasis triggers can help you better manage your symptoms. Get psoriasis treatment strategies to improve your quality of life.

Learn a morning routine for psoriasis that can help relieve your symptoms like itching and pain. A dermatologist offers their top tips. If you have psoriasis, it sometimes feels like you’d do anything ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

Bimekizumab showed durable four-year psoriasis clearance with mechanistic insights into immune memory modulation. Read more ...

Marketing authorisation in Great Britain has been granted for deucravacitinib by the MHRA for use in the treatment of moderate to severe plaque psoriasis in adults. Earlier this year, deucravacitinib ...

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) ...

January's approval by the Food and Drug Administration (FDA) of Amevive, the first biologic treatment for chronic plaque psoriasis, is a qualified blessing for the estimated 1.5 million Americans who ...